Asian hospitals join forces to personalize endometrial cancer care
NCT ID NCT07354087
First seen Jan 27, 2026 · Last updated May 21, 2026 · Updated 16 times
Summary
This study collects data from 300 Asian patients with endometrial cancer to see how doctors use tumor features (like cell type and genetic markers) to choose treatments. The goal is to learn which patients need more or less aggressive therapy, reducing side effects while improving survival. No new treatments are tested—just information gathering to guide future care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre
Navi Mumbai, Maharashtra, 410210, India
-
Tata Memorial Hospital
Mumbai, Maharashtra, 400012, India
Conditions
Explore the condition pages connected to this study.